Anti-Parkinson's Drugs: Global Markets to 2022

  • ID: 4472231
  • Report
  • Region: Global
  • 172 Pages
  • BCC Research
1 of 5
The Global Anti-Parkinson’s Drugs Market should Reach $5.7 Billion by 2022 at a CAGR of 6.1%, from 2017 to 2022

FEATURED COMPANIES

  • ABBVIE
  • BOEHRINGER INGELHEIM
  • F. Hoffmann-La Roche AG
  • NOVARTIS AG
  • UCB SA
  • MORE

Report Scope:

This research report categorizes the anti-Parkinson’s drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications.

Report Includes:

  • 95 data tables
  • An overview of the global market for anti-Parkinson’s drugs and their future demand
  • Analyses of global market trends, with data from 2013-2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Analyses of the major factors and technological advances such as biomarkers, 3D printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson’s disease
  • Discussion of the major segments of the anti-Parkinson’s drugs, i.e., dopaminergic drugs, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications
  • Company profiles of the major players in the market, including AbbVie, Mylan Laboratories, Valeant Pharmaceuticals and Novartis

Key Highlights:

  • The global anti-Parkinson’s drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1%, from 2017 to 2022.
  • Asia Pacific anti-Parkinson’s drugs market is expected to grow from $1.0 billion in 2017 to $1.4 billion in 2022 at a CAGR of 6.4% for the period 2017-2022.
  • North American anti-Parkinson’s drugs market is expected to grow from $1.3 billion in 2017 to $1.8 billion in 2022 at a CAGR of 7.0% for the period 2017-2022.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ABBVIE
  • BOEHRINGER INGELHEIM
  • F. Hoffmann-La Roche AG
  • NOVARTIS AG
  • UCB SA
  • MORE

1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related Research Reports

2 Summary and Highlights

3 Anti-Parkinson's Drugs Market Characteristics

4 Anti-Parkinson's Drugs Market Size and Growth

  • Historic Market Growth
  • Drivers of the Market
  • Restraints on the Market
  • Forecast Market Growth
  • Drivers of the Market
  • Restraints on the Market

5 Anti-Parkinson's Drugs Market Trends and Strategies

  • New Medication to Help the Body Absorb Parkinson’s Disease Medication
  • Free Water Biomarker to Track Changes in Brain
  • 3D Printing Technology

6 PESTLE Analysis

  • Political
  • Government Financial Support
  • Uncertain Political Policies
  • Government Intervention
  • Economic
  • Wealth
  • Globalization
  • Emerging Markets
  • Social
  • Aging Global Population
  • Health Consciousness and Awareness
  • Traditional Medicine Continues to Pose Threat to Market
  • Shortage of Skill
  • Technological
  • Technological Breakthroughs
  • Wearable Technology and Hardware Advancements
  • Internet Penetration and Mobile Applications
  • Legal
  • Stringent Regulations and Long Approval Procedures
  • Tax Exemptions Initiatives and Subsidies
  • Investment Regulations
  • Environmental

7 Anti-Parkinson's Drugs Market Segmentation

  • Global Anti-Parkinson's Drugs Market, by Segment
  • Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
  • Dopaminergics Market
  • Market Characteristics
  • Market Trends and Strategies
  • Dopamine Agonists Market
  • Market Characteristics
  • Market Trends and Strategies
  • Enzyme Inhibitors Market
  • Market Characteristics
  • Market Trends and Strategies
  • Other Anti-Parkinson's Medications Market
  • Market Characteristics

8 Anti-Parkinson's Drugs Market Regional and Country Analysis

  • Global Anti-Parkinson's Drugs Market, by Region
  • Global Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Region
  • Global Anti-Parkinson's Drugs Market Segmentation, by Region, 2017
  • Global Anti-Parkinson's Drugs Market, by Country
  • Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Country
  • Global Anti-Parkinson's Drugs Market Segmentation, 2017, by Country

9 Global Anti-Parkinson's Drugs Market Comparison with Macro Economic Factors

  • Global Per Capita Average Anti-Parkinson's Drugs Market Expenditure
  • Per Capita Average Anti-Parkinson's Drugs Market Expenditure, by Country

10 Asia-Pacific Anti-Parkinson's Drugs Market

  • Asia-Pacific Anti-Parkinson's Drugs Market Overview
  • Region Information
  • Market Information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Export and Import Duties on Anti-Parkinson Drugs
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • Asia-Pacific Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • Asia-Pacific Anti-Parkinson's Drugs Market Forecast Market
  • Asia-Pacific Anti-Parkinson's Drugs Market, by Segment
  • Asia-Pacific Anti-Parkinson's Drugs Market, Historic and Forecast CAGR, by Segment

11 Asia-Pacific Anti-Parkinson's Drugs Market: Country Analysis

  • China Anti-Parkinson's Drugs Market Overview
  • Country Information
  • Market information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Export and Import Duties on Anti-Parkinson Drugs
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • China Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • China Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
  • China Market Size, by Segment
  • China Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • India Anti-Parkinson's Drugs Market Overview
  • Country Information
  • Market Information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Import and Export Duties
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • India Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • India Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
  • India Market Size, by Segment
  • India Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • Japan Anti-Parkinson's Drugs Market Overview
  • Country Information
  • Market Information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Import and Export Duties on Anti-Parkinson Drugs
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • Japan Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • Japan Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
  • Japan Market Size, by Segment
  • Japan Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • Australia Anti-Parkinson's Drugs Market
  • Australia Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • Australia Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
  • Australia Market Size, by Segment
  • Australia Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment

12 Western Europe Anti-Parkinson's Drugs Market

  • Western European Anti-Parkinson's Drugs Market Overview
  • Region Information
  • Market Information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • Western Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Western Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Western Europe Market Size, by Segment
  • Western Europe Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment

13 Western Europe Anti-Parkinson's Drugs Market: Country Analysis

  • UK Anti-Parkinson's Drugs Market Overview
  • Country Information
  • Market information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Export and Import Duties on Anti-Parkinson Drugs
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • UK Anti-Parkinson's Drugs Historic Market, 2013-2017
  • UK Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • UK Market Size, by Segment
  • UK Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • Germany Anti-Parkinson's Drugs Market
  • Germany Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Germany Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Germany Market Size, by Segment
  • Germany Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • France Anti-Parkinson's Drugs Market
  • France Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • France Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • France Market Size, by Segment
  • France Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
  • Italy Anti-Parkinson's Drugs Market
  • Italy Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • Italy Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
  • Italy Market Size, by Segment
  • Italy Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022,
  • Spain Anti-Parkinson's Drugs Market
  • Spain Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • Spain Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Spain Market Size, by Segment
  • Spain Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

14 Eastern Europe Anti-Parkinson's Drugs Market

  • Eastern European Anti-Parkinson's Drugs Market Overview
  • Region Information
  • Market Information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Export and Import Duties On Anti-Parkinson Drugs
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • Eastern Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Eastern Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Eastern Europe Market Size, by Segment
  • Eastern Europe Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

15 Eastern Europe Anti-Parkinson's Drugs Market: Country Analysis

  • Russia Anti-Parkinson's Drugs Market
  • Russia Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Russia Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Russia Market Size, by Segment
  • Russia Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

16 North America Anti-Parkinson's Drugs Market

  • North America Anti-Parkinson's Drugs Market Overview
  • Region Information
  • Market Information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • North America Anti-Parkinson's Drugs Historic Market, 2013-2017
  • North America Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • North America Market Size, by Segment
  • North America Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

17 North America Anti-Parkinson's Drugs Market: Country Analysis

  • USA Anti-Parkinson's Drugs Market
  • USA Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • USA Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
  • USA Market Size, by Segment
  • USA Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment

18 South America Anti-Parkinson's Drugs Market

  • South America Anti-Parkinson's Drugs Market Overview
  • Region Information
  • Market Information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • South America Anti-Parkinson's Drugs Historic Market, 2013-2017
  • South America Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • South America Market Size, by Segment
  • South America Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

19 South America Anti-Parkinson's Drugs Market: Country Analysis

  • Brazil Anti-Parkinson's Drugs Market
  • Brazil Anti-Parkinson's Drugs Historic Market, 2013-2016
  • Brazil Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
  • Brazil Market Size, by Segment
  • Brazil Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

20 Middle East Anti-Parkinson's Drugs Market

  • Middle Anti-Parkinson's Drugs Market Overview
  • Region Information
  • Market information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Major Contracts/Research and Development Projects
  • Regulations
  • Regulatory Bodies
  • Major Associations
  • Competitive Landscape
  • Middle East Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Middle East Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Middle East Market Size, by Segment
  • Middle East Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

21 Africa Anti-Parkinson's Drugs Market

  • Africa Anti-Parkinson's Drugs Market Overview
  • Region Information
  • Market information
  • Prevalence of Parkinson's Disease
  • Government Initiatives
  • Regulatory Bodies
  • Major Associations
  • Export and Import Duties on Anti-Parkinson Drugs
  • Competitive Landscape
  • Africa Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Africa Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Africa Market Size, by Segment
  • Africa Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

22 Anti-Parkinson's Drugs Market Customer Information

  • Significant Impact of Parkinson's Disease on Quality of Life
  • Knowledge Gaps among Parkinson's Patients and Caregivers
  • Parkinson's Awareness in UK
  • Knowledge on Parkinson's Disease among Patients and General Neurologists
  • Power of Placebo

23 Anti-Parkinson's Drugs Market Competitive Landscape

  • Company Profiles
  • ABBVIE
  • BOEHRINGER INGELHEIM
  • F. HOFFMANN-LA ROCHE AG
  • NOVARTIS AG
  • UCB SA

24 Key Mergers and Acquisitions in the Anti-Parkinson's Drugs Market

  • Teva Pharmaceutical Acquired Auspex Pharmaceuticals
  • Mitsubishi Tanabe Acquired NeuroDerm
  • Sunovion Pharmaceuticals Acquired Cynapsus Therapeutics
  • Acorda Therapeutics Acquired Civitas Therapeutics
  • Acorda Therapeutics Acquired Biotie Therapies

25 Appendix

  • Definitions of the Industry
  • Anti-Parkinson's Drugs
  • Research Methodology

26 References

List of Tables:
Summary Table: Global Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 1: Global Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 2: Global Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 3: Global Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 4: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 5: Global Anti-Parkinson’s Drugs Market, by Region, 2017
Table 6: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
Table 7: Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017
Table 8: Global Anti-Parkinson’s Drugs Market, by Country, 2017
Table 9: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
Table 10: Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
Table 11: Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013-2022
Table 12: Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, by Country, 2017
Table 13: Asia-Pacific-Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 14: Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 15: Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 16: Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 17: China Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 18: China Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 19: China Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 20: China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 21: India Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 22: India Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 23: India Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 24: India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 25: Japan Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 26: Japan Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 27: Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 28: Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 29: Australia Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 30: Australia Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 31: Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 32: Australia Anti-Parkinson’s Drugs Market Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 33: Western Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 34: Western Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 35: Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 36: Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 37: UK Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 38: UK Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 39: UK Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 40: UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 41: Germany Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 42: Germany Anti-Parkinson’s Drugs Forecast Market, Through 2022,
Table 43: Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 44: Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 45: France Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 46: France Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 47: France Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 48: France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 49: Italy Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 50: Italy Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 51: Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 52: Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 53: Spain Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 54: Spain Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 55: Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 56: Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 57: Eastern Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 58: Eastern Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 59: Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 60: Eastern Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 61: Russia Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 62: Russia Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 63: Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 64: Russia Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 65: North America Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 66: North America Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 67: North America Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 68: North America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 69: USA Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 70: USA Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 71: USA Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 72: USA Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 73: South America Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 74: South America Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 75: South America Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 76: South America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 77: Brazil Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 78: Brazil Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 79: Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 80: Brazil Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 81: Middle East Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 82: Middle East Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 83: Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 84: Middle East Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 85: Africa Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 86: Africa Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 87: Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 88: Africa Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 89: Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017
Table 90: AbbVie, Inc.: Financial Performance, 2013-2017
Table 91: Boehringer Ingelheim: Financial Performance, 2013-2016
Table 92: F. Hoffmann-La Roche: Financial Performance, 2013-2017
Table 93: Novartis AG: Financial Performance, 2013-2017
Table 94: UCB SA: Financial Performance, 2013-2017
Table 95: Market Data Sources

List of Figures:
Summary Figure: Global Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 1: Global Anti-Parkinson's Drugs Historic Market, 2013-2017
Figure 2: Global Anti-Parkinson's Drugs Forecast Market, 2017-2022
Figure 3: PESTLE Analysis: Global Anti-Parkinson’s Drugs Market, 2017
Figure 4: Global Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 5: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 6: Global Anti-Parkinson’s Drugs Market Share, by Region, 2017
Figure 7: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
Figure 8: Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017,
Figure 9: Global Anti-Parkinson’s Drugs Market Share, by Country, 2017
Figure 10: Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
Figure 11: Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
Figure 12: Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013-2022
Figure 13: Asia-Pacific Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 14: Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 15: Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 16: Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 17: China Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 18: China Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 19: China Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 20: China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 21: India Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 22: India Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 23: India Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 24: India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 25: Japan Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 26: Japan Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 27: Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 28: Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 29: Australia Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 30: Australia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 31: Australia Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 32: Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 33: Western Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 34: Western Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 35: Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 36: Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 37: UK Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 38: UK Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 39: UK Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 40: UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 41: Germany Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 42: Germany Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 43: Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 44: Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 45: France Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 46: France Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 47: France Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 48: France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 49: Italy Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 50: Italy Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 51: Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 52: Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 53: Spain Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 54: Spain Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 55: Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 56: Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 57: Eastern Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 58: Eastern Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 59: Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 60: Eastern Europe Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 61: Russia Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 62: Russia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 63: Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 64: Russia Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 65: North America Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 66: North America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 67: North America Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 68: North America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 69: USA Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 70: USA Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 71: USA Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 72: USA Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 73: South America Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 74: South America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 75: South America Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 76: South America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 77: Brazil Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 78: Brazil Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 79: Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 80: Brazil Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 81: Middle East Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 82: Middle East Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 83: Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 84: Middle East Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 85: Africa Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 86: Africa Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 87: Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 88: Africa Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 89: Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017,
Figure 90: AbbVie Inc.: Financial Performance, 2013-2017
Figure 91: Boehringer Ingelheim: Financial Performance, 2013-2016
Figure 92: F. Hoffmann-La Roche: Financial Performance, 2013-2017
Figure 93: Novartis AG: Financial Performance, 2013-2017
Figure 94: UCB SA: Financial Performance, 2013-2017

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • ABBVIE
  • BOEHRINGER INGELHEIM
  • F. Hoffmann-La Roche AG
  • NOVARTIS AG
  • UCB SA
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll